Stuart Jones - Concepedia

Author

Stuart Jones

Also Known As

Jones, Stuart, S. D. JONES, S.D. Jones, Sherrie Jones, Stewart Jones, Stuart D Jones, Stuart D. Jones, Stuart Jones, Stuart Jones (2112958)

Publications

661

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Manchester Institute University of Manchester University of York University of Bristol AstraZeneca (United Kingdom)

About

Stuart Jones is an author at Cancer Research UK Manchester Institute specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	498
2	Biochemistry	9	9	477
3	Natural Sciences	8	8	431
4	Chemical Biology	3	3	147
5	Engineering	1	1	25

Stuart Jones

Publications

623

Citations

H-Index

Page 1

	Year	Citations
First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib Dominic I. James, Kate M. Smith, Allan M. Jordan, ACS Chemical Biology BiochemistryMedicineNatural SciencesGlycobiologyParg Inhibition	2016	137
PRO_SELECT: Combining Structure-Based Drug Design and Array-Based Chemistry for Rapid Lead Discovery. 2. The Development of a Series of Highly Potent and Selective Factor Xa Inhibitors John W. Liebeschuetz, Stuart Jones, Phillip J. Morgan, Journal of Medicinal Chemistry Drug TargetHit IdentificationBiomolecular Structure PredictionMolecular BiologyLead Identification	2002	85
Novel Steroid Inhibitors of Glucose 6-Phosphate Dehydrogenase Niall M. Hamilton, Martin D. Dawson, Emma Fairweather, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryAldehyde DehydrogenaseAlcohol DehydrogenasesBiochemistry	2012	62
Total Synthesis of an Oxepine Natural Product, (±)-Janoxepin Richard G. Doveston, René R. E. Steendam, Stuart Jones, Organic Letters BiochemistryMedicineFungus Aspergillus JanusMedicinal FungiTotal Synthesis	2012	46
The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity Rebecca Newton, Katherine A. Bowler, Emily M. Burns, European Journal of Medicinal Chemistry Combinatorial ChemistryDrug TargetPharmacotherapyPharmaceutical ChemistryTumor Biology	2016	38
Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells Stuart Jones, Jonathan Ahmet, Kelly Ayton, Journal of Medicinal Chemistry Myeloid DifferentiationAldo-keto ReductaseR132h Idh1Allosteric InhibitorsChemical Biology	2016	37
The synthesis of a C1-C8 lactone fragment of discodermolide Julian M.C. Golec, Stuart Jones Tetrahedron Letters Organic ChemistryReaction IntermediateChemistryC1-c8 Lactone FragmentSynthetic Chemistry	1993	32
Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides Bohdan Waszkowycz, Kate M. Smith, Alison E. McGonagle, Journal of Medicinal Chemistry	2018	32
Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme Julian M.C. Golec, Michael D. Mullican, Mark A. Murcko, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryInterleukin-1β Converting EnzymePharmaceutical ChemistryBiochemistry	1997	25
A four component coupling strategy for the synthesis of d-phenylglycinamide-derived non-covalent factor Xa inhibitors Scott M. Sheehan, John J. Masters, Michael R. Wiley, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryBioorganic ChemistryBiochemistryNatural Sciences	2003	25

Page 1